| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |